Conference Reports for NATAP

20th International AIDS Conference July 20-25, 2014 Melbourne, Australia Back

Tweet

HIV Cure Reports, "Towards a Cure" Symposium at IAC       IAS pre-meeting "Towards a Cure" Symposium - David Margolis MD, UNC Chapel Hill - (08/06/14)   FUNCTIONAL CURE AND SEROREVERSION AFTER ADVANCED HIV DISEASE FOLLOWING 7 YEARS OF ANTIRETROVIRAL TREATMENT INTERRUPTION - (08/06/14)   -----No HIV RNA or DNA, Negative Western Blot, After 7-Year ART Suspension - Mark Mascolini - (08/04/14)   Raltegravir May Offer Gut Microbe Advantages Compared With Nonnucleosides - Mark Mascolini - (08/04/14)   -----SIV-infected rhesus macaques receiving suppressive cART have continued GI damage, inflammation, immune activation and persistent low-level viral replication within lymphoid tissues Suggesting that HIV Cure strategies will need to address sources of residual inflammation/immune activation to be successful" - (07/28/14)   The HDAC inhibitor romidepsin is safe and effectively reverses HIV-1 latency in vivo as measured by standard clinical assays - (07/22/14)   Treatment with the histone deacetylase inhibitor Panobinostat markedly reduces chronic inflammation in HIV-infected patients - (07/29/14)   Allogeneic bone marrow transplantation in two HIV-1 infected patients shows no detectable HIV-1 RNA or DNA, and a profound reduction in HIV-1 antibodies - (07/28/14)   Resistance Mutations Persist in HIV DNA After 12 Years With Undetectable Viral Load - Mark Mascolini - (07/25/14)   cART in First Days of Life Limits Viral Reservoir Size in 4 Canadian Children - written by Mark Mascolini - (07/22/14)